Knowable Magazine reports that studying dogs' cancers offers insights into human cancer, due to similar pathways and faster ...

A new preclinical study from Scripps Research suggests that a drug already approved by the U.S. Food and Drug Administration ...

"He barely lifted his head off his bed and I knew something was really wrong," Kassidy Ciarrone told Newsweek.

Broader formulary coverage is associated with lower odds of multiple sclerosis (MS) relapse among Medicare beneficiaries, according to a study published online Aug. 1 in JAMA Network Open. Barbara ...

Hayes is opening up about a family tragedy -- and the lucky twist of fate that kept him from breaking sobriety on one of the ...

The research suggests common respiratory infections, such as the flu or COVID, are capable of stirring dormant cancer cells ...

Drug formulary restrictions in Medicare plans are linked to an increased risk for relapse in patients with multiple sclerosis ...

Early withdrawal of a treatment for patients with a rare kidney disease is possible without relapse, safer for patients and ...

Professor Xun Lan from the School of Basic Medical Sciences at Tsinghua University and Director Hongxing Liu from Hebei Yanda ...

During a live event, Matthew Lunning, DO, and participants discussed the process of determining if patients with DLBCL should ...

Why do so many people relapse after quitting cocaine? A new study from The Hebrew University reveals that a specific "anti-reward" brain circuit becomes hyperactive during withdrawal—driving ...

Overall, 26% of patients with giant cell arteritis experienced a relapse, primarily within the first 2 years of diagnosis. Relapses are relatively common in giant cell arteritis (GCA) and often occur ...